2026 International Congress Archives - Page 84 of 208

Exploring the Causal Role of Mitochondria-related Genes in Parkinson’s Disease through Multi-Omics Mendelian Randomization

Y. Zhang, M. Niu (Shanghai, China)
Exploring the Genetic Architecture of Parkinson’s Disease in North Africa

S. Hrir, H. Nehdi, T. Lüth, C. Gabbert, A. Fienemann, S. Schaake, T. Kleinz, Y. Kanana, F. Nabli, R. Zouari, D. Ben Mohamed, A. Rachdi, Z. Saied, R. Amouri, M. Farrer, F. Hentati, C. Klein, S. Ben Sassi, J. Trinh, GP2. Genetics Program (Lübeck, Germany)
Exploring the Genetic Landscape of Corticobasal Syndrome in Asian Populations

CY. Liu, PS. Chen, MZ. Hung, NC. Lee, SP. Fan, CH. Lee, CH. Tai, HL. Chiang, CY. Chen, YR. Wu, YY. Chang, CS. Lu, T. Nomura, H. Yaguchi, TS. Toh, AH. Tan, EK. Tan, I. Yabe, SY. Lim, CH. Lin (Taipei, Taiwan)
Exploring the Impact of Parameter Selection on Digital Sleep Outcomes in Parkinson’s Disease: Results from the IDEA-FAST Study

M. Sedghi, S. Del Din, W-F. Ng, W. Maetzler, NV. Manyakov, S. Avey, R. Göder, C. Pinaud, M. Chatterjee, RZ. Ur Rehman, JP. Taylor, L. Alcock, RA. Lawson (Newcastle upon Tyne, United Kingdom)
Exploring the Relationship Between Circadian Disruption, Depression and Suicidal Ideation in People with Huntington’s Disease (Mind & Clock Study)

A. Rangel Cristales, A. Hampshire, D. van Wamelen (London, United Kingdom)
Exploring the Relationship Between Insomnia and Autonomic Dysfunction in Parkinson’s Disease: A 1 Year SCOPA-AUT Analysis

D. Petrosyan, P. Bhaya, P. Coss, S. Horn, E. Vaou, L. Saadatpour (San Antonio, USA)
Exploring the variability in spoken language comprehension, speech and functional communication in children with GNAO1-associated disorder: a case series

L. Heideman, J. Geytenbeek, N. Wolf, A. Buizer, L. Vande Pol (Amsterdam, Netherlands)
Exploring Usability and Feasibility of an Optimised Smartwatch to Monitor Medication Intake in Parkinson’s Disease

E. Packer, K. Scott, P. Brown, J. Sarvestan, A. Smalley, O. Brugna, N. Ireson, V. Lanfranchi, L. Rochester, A. Yarnall, L. Alcock, M. Peeters, S. Del Din (United Kingdom)
Exposure-Response Analysis of Glovadalen in the ATLANTIS Phase II Study: Trial Simulation Explains Dose-Response for OFF Time in Parkinson’s

D. Menshykau, M. Biagioni, C. Beuter, C. Legendre, A. Benoit, L. Vroye, B. Klünder, M. Faisal, S. Leach, R. Nicholl, H. Naik (Monheim am Rhein, Germany)
Extended long-term follow-up of adaptive deep brain stimulation in Parkinson’s disease

T. Herrington, A. Ramirez-Zamora, M. Beudel, S. Little, J. Ostrem, L. Almeida, A. Fasano, T. Hassell, K. Mitchell, E. Moro, N. Sarangmat, M. Gostkowski, L. Tonder, Y. Tan, R. Summers, T. Goble, S. Stanslaski, H. Bronte-Stewart (Boston, USA)